Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Andrew V Schally
2018

Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis

Popovics, P., Cai, R., Sha, W., Rick, F. G. & Schally, A. V., Sep 15 2018, In : Prostate. 78, 13, p. 970-980 11 p.

Research output: Contribution to journalArticle

10 Scopus citations

Somatostatin receptors as molecular targets in human uveal melanoma

Harda, K., Szabo, Z., Szabo, E., Olah, G., Fodor, K., Szasz, C., Mehes, G., Schally, A. V. & Halmos, G., Jan 1 2018, In : Molecules. 23, 7, 1535;.

Research output: Contribution to journalArticle

2014
Open Access
18 Scopus citations
2013

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone

Jaszberenyi, M., Schally, A. V., Block, N. L., Nadji, M., Vidaurre, I., Szalontay, L. & Rick, F. G., Mar 2013, In : Oncotarget. 4, 3, p. 422-432 11 p.

Research output: Contribution to journalArticle

Open Access
18 Scopus citations
2015

Transplantation of bovine adrenocortical cells encapsulated in alginate

Balyura, M., Gelfgat, E., Ehrhart-Bornstein, M., Ludwig, B., Gendlerc, Z., Barkai, U., Zimerman, B., Rotem, A., Block, N. L., Schally, A. V. & Bornstein, S. R., Feb 24 2015, In : Proceedings of the National Academy of Sciences of the United States of America. 112, 8, p. 2527-2532 6 p.

Research output: Contribution to journalArticle

23 Scopus citations
2013

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma

Treszl, A., Steiber, Z., Schally, A. V., Block, N. L., Dezso, B., Olah, G., Rozsa, B., Fodor, K., Buglyo, A., Gardi, J., Berta, A. & Halmos, G., Oct 2013, In : Oncotarget. 4, 10, p. 1721-1728 8 p.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations
2018

Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields

Stewart, T. S., Nagesetti, A., Guduru, R., Liang, P., Stimphil, E., Hadjikhani, A., Salgueiro, L., Horstmyer, J., Cai, R., Schally, A. V. & Khizroev, S., Feb 1 2018, In : Nanomedicine. 13, 4, p. 423-438 16 p.

Research output: Contribution to journalArticle

6 Scopus citations
2016

Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone

Kiscsatári, L., Varga, Z., Schally, A. V., Gáspár, R., Nagy, C. T., Giricz, Z., Ferdinandy, P., Fábián, G., Kahán, Z. & Görbe, A., Sep 1 2016, In : Pharmacological Research. 111, p. 859-866 8 p.

Research output: Contribution to journalArticle

3 Scopus citations
2011

Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix

Rozsa, B., Nadji, M., Schally, A. V., Dezso, B., Flasko, T., Toth, G., Mile, M., Block, N. L. & Halmos, G., Apr 1 2011, In : Prostate. 71, 5, p. 445-452 8 p.

Research output: Contribution to journalArticle

13 Scopus citations
2012

Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins

Stangelberger, A., Schally, A. V., Rick, F. G., Varga, J. L., Baker, B., Zarandi, M. & Halmos, G., Apr 1 2012, In : Prostate. 72, 5, p. 555-565 11 p.

Research output: Contribution to journalArticle

26 Scopus citations
2018

Expression of progenitor markers is associated with the functionality of a bioartificial adrenal cortex

Balyura, M., Gelfgat, E., Steenblock, C., Androutsellis-Theotokis, A., Ruiz-Babot, G., Guasti, L., Werdermann, M., Ludwig, B., Bornstein, T., Schally, A. V., Brennand, A. & Bornstein, S. R., Mar 1 2018, In : PLoS One. 13, 3, e0194643.

Research output: Contribution to journalArticle

5 Scopus citations
2012

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers

Perez, R., Schally, A. V., Vidaurre, I., Rincon, R., Block, N. L. & Rick, F. G., Sep 2012, In : Oncotarget. 3, 9, p. 988-997 10 p.

Research output: Contribution to journalArticle

Open Access
32 Scopus citations
2013

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers

Seitz, S., Rick, F. G., Schally, A. V., Treszl, A., Hohla, F., Szalontay, L., Zarandi, M., Ortmann, O., Engel, J. B. & Buchholz, S., Jul 1 2013, In : Oncology Reports. 30, 1, p. 413-418 6 p.

Research output: Contribution to journalArticle

19 Scopus citations
2014

Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities

Cai, R., Schally, A. V., Cui, T., Szalontay, L., Halmos, G., Sha, W., Kovacs, M., Jaszberenyi, M., He, J., Rick, F. G., Popovics, P., Kanashiro-Takeuchi, R., Hare, J. M., Block, N. L. & Zarandi, M., Feb 1 2014, In : Peptides. 52, p. 104-112 9 p.

Research output: Contribution to journalArticle

32 Scopus citations
2012

Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells

Vacas, E., Bajo, A. M., Schally, A. V., Sánchez-Chapado, M., Prieto, J. C. & Carmena, M. J., Dec 1 2012, In : Peptides. 38, 2, p. 275-281 7 p.

Research output: Contribution to journalArticle

11 Scopus citations
2013

Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108

Szepeshazi, K., Schally, A. V., Block, N. L., Halmos, G., Nadji, M., Szalontay, L., Vidaurre, I., Abi-Chaker, A. & Rick, F. G., May 2013, In : Oncotarget. 4, 5, p. 751-760 10 p.

Research output: Contribution to journalArticle

Open Access
14 Scopus citations

Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma

Vacas, E., Bajo, A. M., Schally, A. V., Sánchez-Chapado, M., Prieto, J. C. & Carmena, M. J., Jan 3 2013, In : Molecular and Cellular Endocrinology. 365, 2, p. 212-222 11 p.

Research output: Contribution to journalArticle

13 Scopus citations
2015
21 Scopus citations
2017

The effects of a growth hormone-releasing hormone antagonist and a gastrin-releasing peptide antagonist on intimal hyperplasia of the carotid artery after balloon injury in a diabetic rat model

Moscona, J. C., Peters, M. N., Schally, A. V., Srivastav, S., Delafontaine, P. & Irimpen, A., Sep 1 2017, In : Artery Research. 19, p. 56-64 9 p.

Research output: Contribution to journalArticle

2018

Structural motif descriptors as a way to elucidate the agonistic or antagonistic activity of growth hormone-releasing hormone peptide analogues

Jeanne Dit Fouque, K., Salgueiro, L. M., Cai, R., Sha, W., Schally, A. V. & Fernandez-Lima, F., Jul 6 2018, In : ACS Omega. 3, 7, p. 7432-7440 9 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations
2011

GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells

Siejka, A., Barabutis, N. & Schally, A. V., Nov 1 2011, In : Cell Cycle. 10, 21, p. 3714-3718 5 p.

Research output: Contribution to journalArticle

18 Scopus citations
2018

Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer

Khanlari, M., Schally, A. V., Block, N. L. & Nadji, M., Jan 1 2018, In : Applied Immunohistochemistry and Molecular Morphology. 26, 1, p. 1-5 5 p.

Research output: Contribution to journalArticle

2012

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

Rick, F. G., Seitz, S., Schally, A. V., Szalontay, L., Krishan, A., Datz, C., Stadlmayr, A., Buchholz, S., Block, N. L. & Hohla, F., Nov 15 2012, In : Cell Cycle. 11, 22, p. 4203-4210 8 p.

Research output: Contribution to journalArticle

Open Access
13 Scopus citations
2014

Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus

Ludwig, B., Barthel, A., Reichel, A., Block, N. L., Ludwig, S., Schally, A. V. & Bornstein, S. R., Feb 25 2014, In : Vitamins and Hormones. 95, p. 195-222 28 p.

Research output: Contribution to journalArticle

7 Scopus citations
2017

Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure

Gesmundo, I., Miragoli, M., Carullo, P., Trovato, L., Larcher, V., Di Pasquale, E., Brancaccio, M., Mazzola, M., Villanova, T., Sorge, M., Taliano, M., Gallo, M. P., Alloatti, G., Penna, C., Hare, J. M., Ghigo, E., Schally, A. V., Condorelli, G. & Granata, R., Nov 7 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 45, p. 12033-12038 6 p.

Research output: Contribution to journalArticle

12 Scopus citations
2012

AEZS-108: A targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors

Engel, J., Emons, G., Pinski, J. & Schally, A. V., Jun 1 2012, In : Expert opinion on investigational drugs. 21, 6, p. 891-899 9 p.

Research output: Contribution to journalReview article

67 Scopus citations
2015

Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2

Catanuto, P., Tashiro, J., Rick, F. G., Sanchez, P., Solorzano, C. C., Glassberg Csete, M. K., Block, N. L., Lew, J., Elliot, S. & Schally, A. V., Mar 10 2015, (Accepted/In press) In : Hormones and Cancer.

Research output: Contribution to journalArticle

5 Scopus citations
2016

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy

Crawford, E. D., Schally, A. V., Pinthus, J. H., Block, N. L., Rick, F. G., Garnick, M. B., Eckel, R. H., Keane, T. E., Shore, N. D., Dahdal, D. N., Beveridge, T. J. R. & Marshall, D. C., Aug 1 2016, (Accepted/In press) In : Urologic Oncology: Seminars and Original Investigations.

Research output: Contribution to journalArticle

25 Scopus citations
2013

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer

Rick, F. G., Block, N. L. & Schally, A. V., Apr 23 2013, In : OncoTargets and Therapy. 6, p. 391-402 12 p.

Research output: Contribution to journalArticle

30 Scopus citations
2015

CKit+ cardiac progenitors of neural crest origin

Hatzistergos, K. E., Takeuchi, L. M., Saur, D., Seidler, B., Dymecki, S. M., Mai, J. J., White, I. A., Balkan, W. E., Takeuchi, R., Schally, A. V. & Hare, J., Oct 20 2015, In : Proceedings of the National Academy of Sciences of the United States of America. 112, 42, p. 13051-13056 6 p.

Research output: Contribution to journalArticle

60 Scopus citations
2014

Erratum: Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States of America (2014) 111, 7 (2686-2691) DOI: 10.1073/pnas.1400419111)

Chatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., Van Den Berg, S., Van Den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Ameln, A. K. V., Gijbels, M., Noelle, R., Boon, L., Hackeng, T. & 16 others, Schulte, K. M., Xu, A., Vriend, G., Nabuurs, S., Chung, K. J., Van Dijk, K. W., Rensen, P. C. N., Gerdes, N., De Winther, M., Block, N. L., Schally, A. V., Weber, C., Bornstein, S. R., Nicolaes, G., Chavakis, T. & Lutgens, E., Mar 25 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 12, 1 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
2017

Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer

Zoltan, L., Farkas, R., Schally, A. V., Pozsgai, E., Papp, A., Bognár, L., Tornoczki, T., Mangel, L. & Bellyei, S., Nov 4 2017, (Accepted/In press) In : Pathology and Oncology Research. p. 1-10 10 p.

Research output: Contribution to journalArticle

2012

Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: Involvement of toll-like receptor 4 signaling

Petronilho, F., Vuolo, F., Galant, L. S., Constantino, L., Tomasi, C. D., Giombelli, V. R., de Souza, C. T., da Silva, S. D., Barbeiro, D. F., Soriano, F. G., Streck, E. L., Ritter, C., Zanotto-Filho, A., Pasquali, M. A., Gelain, D. P., Rybarczyk-Filho, J. L., Moreira, J. C. F., Block, N. L., Roesler, R., Schwartsmann, G. & 2 others, Schally, A. V. & Dal-Pizzol, F., Aug 1 2012, In : Molecular Medicine. 18, 8, p. 1209-1219 11 p.

Research output: Contribution to journalArticle

13 Scopus citations
2014

Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance

Chatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., Van Den Berg, S., Van Den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Ameln, A. K. V., Gijbels, M., Noelle, R., Boon, L., Hackeng, T. & 16 others, Schulte, K., Xu, A., Vriend, G., Nabuurs, S., Chung, K. J., Van Dijk, K. W., Rensen, P. C. N., Gerdes, N., De Winther, M., Block, N. L., Schally, A. V., Weber, C., Bornstein, S. R., Nicolaes, G., Chavakis, T. & Lutgens, E., Feb 18 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 7, p. 2686-2691 6 p.

Research output: Contribution to journalArticle

Open Access
77 Scopus citations
2011

Reply to Liu et al. Hypothalamic control of islets

Schmid, J., Ludwig, B., Schally, A. V., Steffen, A., Ziegler, C. G., Block, N. L., Koutmani, Y., Brendel, M. D., Karalis, K. P., Simeonovic, C. J., Licinio, J., Ehrhart-Bornstein, M. & Bornstein, S. R., Dec 20 2011, In : Proceedings of the National Academy of Sciences of the United States of America. 108, 51, p. E1391

Research output: Contribution to journalLetter

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Rick, F. G., Schally, A. V., Block, N. L., Nadji, M., Szepeshazi, K., Zarandi, M., Vidaurre, I., Perez, R., Halmos, G. & Szalontay, L., Mar 1 2011, In : Proceedings of the National Academy of Sciences of the United States of America. 108, 9, p. 3755-3760 6 p.

Research output: Contribution to journalArticle

52 Scopus citations
2013

Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia

Rick, F. G., Schally, A. V., Block, N. L., Abi-Chaker, A., Krishan, A. & Szalontay, L., Jun 1 2013, In : Prostate. 73, 8, p. 873-883 11 p.

Research output: Contribution to journalArticle

19 Scopus citations
2020

Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target

Xiong, X., Ke, X., Wang, L., Yao, Z., Guo, Y., Zhang, X., Chen, Y., Pang, C. P., Schally, A. V. & Zhang, H., Mar 24 2020, In : Proceedings of the National Academy of Sciences of the United States of America. 117, 12, p. 6726-6732 7 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
2019

Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin

Zhang, C., Cai, R., Lazerson, A., Delcroix, G., Wangpaichitr, M., Mirsaeidi, M., Griswold, A. J., Schally, A. V. & Jackson, R. M., Oct 1 2019, In : Lung. 197, 5, p. 541-549 9 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations
2011

Growth hormone releasing hormone induces the expression of nitric oxide synthase

Barabutis, N., Siejka, A. & Schally, A. V., May 1 2011, In : Journal of Cellular and Molecular Medicine. 15, 5, p. 1148-1155 8 p.

Research output: Contribution to journalArticle

16 Scopus citations
2012

Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers

Klukovits, A., Schally, A. V., Szalontay, L., Vidaurre, I., Papadia, A., Zarandi, M., Varga, J. L., Block, N. L. & Halmos, G., Feb 1 2012, In : Cancer. 118, 3, p. 670-680 11 p.

Research output: Contribution to journalArticle

20 Scopus citations
2014

In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma

Ullrich, M., Bergmann, R., Peitzsch, M., Cartellieri, M., Qin, N., Ehrhart-Bornstein, M., Block, N. L., Schally, A. V., Pietzsch, J., Eisenhofer, G., Bornstein, S. R. & Ziegler, C. G., Nov 1 2014, In : Endocrinology. 155, 11, p. 4149-4156 8 p.

Research output: Contribution to journalArticle

9 Scopus citations
2018

Induction of apoptosis in pterygium cells by antagonists of growth hormone–releasing hormone receptors

Qin, Y. J., Chu, W. K., Huang, L., Ng, C. H. Y., Chan, T. C. Y., Cao, D., Yang, C., Zhang, L., Huang, S. P., Li, J., Lin, H. L., Li, W. Q., Chen, L., Schally, A. V., Chan, S. O., Zhang, H. Y. & Pang, C. P., Oct 1 2018, In : Investigative Ophthalmology and Visual Science. 59, 12, p. 5060-5066 7 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2013

Legends in urology.

Schally, A. V., Oct 2013, In : The Canadian journal of urology. 20, 5, p. 6889-6892 4 p.

Research output: Contribution to journalArticle

2016

GHRH receptor expression in malignant mixed müllerian tumors: A potentially targetable biopredictor

Mackrides, N., Ganjei-Azar, P., Perez, R., Cui, T., Block, N., Schally, A. V. & Nadji, M., Jan 1 2016, In : International Journal of Gynecological Pathology. 35, 2, p. 142-146 5 p.

Research output: Contribution to journalArticle

4 Scopus citations
2012

Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice

Telegdy, G. & Schally, A. V., Jul 15 2012, In : Behavioural Brain Research. 233, 1, p. 232-236 5 p.

Research output: Contribution to journalArticle

10 Scopus citations
2013

Hormonal manipulation of benign prostatic hyperplasia

Rick, F. G., Saadat, S. H., Szalontay, L., Block, N. L., Kazzazi, A., Djavan, B. & Schally, A. V., Jan 1 2013, In : Current opinion in urology. 23, 1, p. 17-24 8 p.

Research output: Contribution to journalReview article

15 Scopus citations
2012

Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage

Rick, F. G., Szalontay, L., Schally, A. V., Block, N. L., Nadji, M., Szepeshazi, K., Vidaurre, I., Zarandi, M., Kovacs, M. & Rekasi, Z., Apr 1 2012, In : Journal of Urology. 187, 4, p. 1498-1504 7 p.

Research output: Contribution to journalArticle

28 Scopus citations
2018

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines

Sipos, E., Dobos, N., Rozsa, D., Fodor, K., Olah, G., Szabo, Z., Szekvolgyi, L., Schally, A. V. & Halmos, G., Feb 22 2018, In : OncoTargets and Therapy. 11, p. 933-941 9 p.

Research output: Contribution to journalArticle

3 Scopus citations